Bank of Montreal Stock: Price, Forecast & Buy Analysis

Bank of Montreal (BMO) stock has spent much of 2025 running ahead of Wall Street’s consensus targets—trading above $152 on the NYSE while the average analyst price target sits at $128.83. That gap creates both a challenge and a signal for investors trying to decide whether BMO is worth owning today. Here’s what the analyst consensus actually says, and what it means for anyone weighing BMO as an investment right now.

Market Cap: 107.74B ·
Current Price: $152.17 ·
Dividend Yield: 3.21% ·
P/E Ratio: 17.59 ·
Beta: 0.94

What happened to Bank of Montreal stock?

Recent price movements

Bank of Montreal stock has traded in a range that sits awkwardly between bearish analyst targets and the current market price. The NYSE listing (BMO) currently trades around $152.15, according to Benzinga market data. That’s notably above the consensus price target of $128.83 derived from 6 analysts—a gap that suggests either the market is running ahead of fundamentals, or Wall Street is being too conservative.

The discrepancy widens when you look at individual targets. Scotiabank issued a low target of $112 back in October 2025, while RBC Capital pushed the high mark to $163 on October 3, 2025. That’s a $51 spread between the most bullish and bearish institutional voices, reflecting genuine uncertainty about where BMO is headed over the next 12 months.

Key events impacting BMO

RBC Capital has been the most active voice on BMO in recent months, issuing ratings on February 26, August 27, and October 3, 2025. The October 3 update set the $163 target with an implied 7.13% upside, per Benzinga research. That followed an earlier upgrade to $161 on January 9, 2025, showing a steady upward revision over the year.

Meanwhile, National Bank Financial raised its TSX target to C$173 from C$161, and TD Cowen made the most aggressive move, upgrading BMO to Buy from Hold and lifting its target to CA$209 from CA$184, according to Marketscreener consensus data. These recent upgrades paint a picture of institutional confidence building—but the targets still don’t catch up to where the stock is already trading.

Is BMO a good stock to buy?

Pros and cons of investing

Yahoo Finance has tagged BMO as “Could Be a Great Choice,” though that framing reflects the dividend and valuation picture more than near-term capital appreciation. For income-focused Canadian investors, the 3.21% yield is the headline story. For growth-oriented holders, the tension between consensus targets and current price is the real question mark.

Comparison to industry

Among Canadian banks, BMO’s positioning is middle-of-the-pack in terms of analyst enthusiasm. Marketscreener’s Outperform consensus from 15 analysts puts BMO ahead of strictly Neutral peers, but below the most bullish calls on some rivals. The rating distribution—Moderate Buy on Barchart, Buy on Investing.com, Outperform on Marketscreener—shows consistency in the positive direction but variation in degree.

The pattern: BMO is a quality name in a competitive sector, with analyst consensus tilted positive but not exuberant. The buy case rests on income generation and relative stability rather than explosive upside potential—assuming the analyst consensus reflects genuine value rather than conservative benchmarking.

What is the future price of BMO stock?

Forecast and price targets

Forecasting BMO’s path requires reconciling multiple analyst datasets that don’t always agree. The most comprehensive TSX view comes from TipRanks analyst forecast data, which shows an average price target of C$172.28 based on 11 analysts, with a high of C$185.00 and low of C$157.00. That’s roughly in line with the current CAD price around C$180, suggesting limited headroom on the TSX in the base case.

Marketscreener’s 15-analyst consensus offers an average target of C$168.07, with a high of C$180.00 and low of C$146.00—wider dispersion reflecting genuine disagreement. Alpha Spread modeling estimates take a more aggressive view, projecting an average of C$211.36 with a high of C$235.20 and low of C$195.94. The higher Alpha Spread numbers may reflect different modeling assumptions or a longer time horizon.

The dispersion across these sources underscores how modeling choices affect where analysts land. TipRanks and Marketscreener cluster around C$168–172, while Alpha Spread’s more optimistic assumptions push toward C$211—investors should weigh which methodology aligns with their expectations.

For USD targets on the NYSE listing, Benzinga analyst ratings reports a consensus of $128.83 from 6 analysts, with RBC Capital’s high of $163 versus Scotiabank’s low of $112. Investing.com shows an average 12-month target of $153.40 with 18.62% upside—but that conflicts with Benzinga’s lower consensus, highlighting how different data sources and polling windows produce divergent views.

Analyst predictions

The broker coverage list reads like a who’s-who of institutional research: RBC Capital Markets, TD Securities, UBS, Barclays, and National Bank Financial all cover BMO, per Marketscreener coverage list. Recent upgrades from National Bank Financial and TD Cowen suggest the tone is improving, even if the targets haven’t universally caught up to current prices.

Is BMO undervalued?

Valuation metrics

Bank of Montreal’s current valuation metrics paint a nuanced picture. A P/E ratio of 17.59 sits comfortably within the range typical for major Canadian banks, neither screaming cheap nor appearing stretched. The 3.21% dividend yield is the more compelling argument for value—it represents meaningful income in an environment where savings rates remain muted for retail investors.

Market capitalization of 107.74B reflects a top-five Canadian bank by size, giving BMO the scale and stability that comes with systemic importance. Beta of 0.94 indicates volatility roughly in line with the broader market—a counterpoint to the narrative that bank stocks are inherently defensive. In practice, this means BMO moves with the market rather than carving out independent trends.

Peer comparison

Across the major Canadian bank peers, BMO’s metrics land squarely in the middle of typical ranges for the sector.

When positioned against peers, BMO doesn’t stand out as dramatically undervalued. The consensus rating of Moderate Buy on Barchart and Outperform on Marketscreener reflects positive but measured sentiment. TipRanks shows 3 Buy, 8 Hold, 0 Sell on the TSX—distribution that suggests analysts see BMO as a solid hold rather than a compelling buy at current levels.

Is there a problem with BMO right now?

Current status and outages

Publicly available data shows no widespread operational outages or service disruptions reported for Bank of Montreal in the recent period covered by analyst research. From a market perspective, the “problem” narrative is less about operational issues and more about valuation—a bank that’s performing adequately but trading where it does means less upside cushion than investors typically want.

The real concern for prospective investors isn’t operational risk but timing risk: buying a stock whose analyst targets have been revised upward but still lag the current price creates a gap that requires continued positive catalysts to close. If BMO reports flat or declining earnings in upcoming quarters, the valuation story deteriorates quickly.

Operational issues

No significant regulatory actions or major operational red flags appear in the covered research period. Analysts covering BMO include major institutional names—RBC Capital Markets, TD Securities, UBS, Barclays, National Bank Financial—whose continued coverage and recent upgrades suggest institutional confidence in the underlying business.

The risk isn’t that something is broken; it’s that the stock’s current price already prices in a lot of good news. Marketscreener shows a high target of C$180.00 representing only 9.61% upside from recent close on the TSX. That’s a narrow margin for a 12-month investment horizon, leaving little room for disappointment.